IndraLab

Statements


USP9X inhibits TP53. 5 / 5
| 5

reach
"In conclusion, this study revealed that miR-26b regulation was a mechanism involved in the sensitivity of HCC cell lines to doxorubicin directly through USP9X dependent degradation of p53 and regulation of autophagy."

reach
"It also confers doxorubicin sensitivity of hepatocellular carcinoma through USP9X dependent degradation of p53 [XREF_BIBR]."

reach
"USP9X deficient cells promoted p53 degradation suggesting it to be considered as a potential therapeutic modulator in p53 related tumors."

reach
"miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X dependent degradation of p53 and regulation of autophagy."

reach
"WP1130 also increases sensitivity to doxorubicin via degrading p53 by a USP9X dependent mechanism in HCC cells XREF_BIBR."